Skip to Main Content

Paper Details

A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies.
Drug Discov Today
7
2022
Author NameAffiliation
Wenzhong XiaoHarvard Medical School, USA Massachusetts General Hospital
Weida TongNational Center for Toxicological Research
Weida TongNational Center for Toxicological Research
Minjun ChenNational Center for Toxicological Research
  • 1 - 4

Datasets

Release 1.2